BKV (NYSE:BKV) CFO Sells $38,445.00 in Stock

BKV Corporation (NYSE:BKV) CFO David Tameron sold 1,500 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $25.63, for a total transaction of $38,445.00. Following the sale, the chief financial officer directly owned 57,024 shares of the company’s stock, valued at approximately $1,461,525.12. This represents a 2.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Tameron also recently made the following trade(s):

• On Thursday, August 20th, David Tameron sold 4,321 shares of BKV stock. The stock was sold at an average price of $26.56, for a total transaction of $114,765.76.

BKV Stock Performance

NYSE BKV traded down $1.91 during trading hours on Friday, reaching $24.19. The company’s stock had a trading volume of 905,259 shares, compared to its average volume of 888,367. The company has a current ratio of 1.15, a quick ratio of 1.10 and a debt-to-equity ratio of 0.45. The business has a 50-day simple moving average of $25.55 and a 200 day simple moving average of $27.64. BKV Corporation has a 52 week low of $20.08 and a 52 week high of $32.81. The stock has a market cap of $2.65 billion, a PE ratio of 8.83 and a beta of 1.08.

BKV (NYSE:BKV) last posted its earnings results on Thursday, August 6th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.25 by $0.21. The company had revenue of $465.54 million during the quarter, compared to analyst estimates of $355.25 million. BKV had a return on equity of 6.68% and a net margin of 17.73%. Equities research analysts predict that BKV Corporation will post 1.77 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on BKV. Jefferies Financial Group reaffirmed a “buy” rating and issued a $34.00 target price on shares of BKV in a research report on Friday, July 10th. Citigroup lowered their price target on shares of BKV from $36.00 to $33.00 and set a “buy” rating for the company in a research report on Thursday, June 11th. Susquehanna dropped their price objective on shares of BKV from $37.00 to $35.00 and set a “positive” rating on the stock in a report on Tuesday, July 21st. Wall Street Zen upgraded shares of BKV from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Finally, Barclays boosted their target price on shares of BKV from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $34.25.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in BKV. Moore Capital Management LP bought a new position in shares of BKV in the second quarter worth $2,001,000. IMC Chicago LLC bought a new stake in shares of BKV during the second quarter valued at about $662,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in BKV by 37.1% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 30,084 shares of the company’s stock worth $823,000 after purchasing an additional 8,144 shares during the period. Empowered Funds LLC acquired a new stake in BKV in the second quarter worth about $1,361,000. Finally, Value Aligned Research Advisors LLC bought a new position in BKV in the 2nd quarter valued at about $18,602,000.

About BKV

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas. BKV Corporation, LLC operates as a subsidiary of Banpu North America Corporation.